Infant Bacterial Therapeutics AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was SEK 29.164 million compared to SEK 27.915 million a year ago. Net loss was SEK 29.165 million compared to SEK 27.937 million a year ago. For the half year, operating loss was SEK 28.712 million compared to SEK 26.708 million a year ago. Net loss was SEK 28.714 million compared to SEK 26.759 million a year ago.